SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $112

Morgan Stanley maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $106 to $112.

 · 
Morgan Stanley maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $106 to $112.